alaproclate has been researched along with cyclic gmp in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartfai, T; Danielsson, E; Nordström, O; Ogren, SO; Peterson, LL | 1 |
| Hu, PS; Ross, SB | 1 |
2 other study(ies) available for alaproclate and cyclic gmp
| Article | Year |
|---|---|
In vivo and in vitro studies on the potentiation of muscarinic receptor stimulation by alaproclate, a selective 5-HT uptake blocker.
Topics: Alanine; Animals; Brain; Cyclic GMP; Drug Synergism; Hippocampus; Male; Mice; Oxotremorine; Physostigmine; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Receptors, Serotonin; Tremor | 1985 |
NMDA receptor-mediated increase in cyclic GMP in the rat cerebellum in vivo is blocked by alaproclate and GEA-857.
Topics: 4-Aminopyridine; Alanine; Animals; Behavior, Animal; Cerebellum; Convulsants; Cyclic GMP; Drug Interactions; Harmaline; Male; N-Methylaspartate; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Seizures; Selective Serotonin Reuptake Inhibitors; Valine | 1997 |